Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.
Apr 15, 2024
0
102
The recent global mpox outbreak trained a bright spotlight on the need for safe and effective Orthopoxvirus vaccines, especially in light of continuously looming zoonotic threats and the potential for these pathogens to spread ...
Dengue, caused by the virus transmitted by the bite of the female Aedes aegypti mosquito and, to a lesser extent, the Aedes albopictus mosquito, is an acute illness characterized mainly by high fever, body aches, and redness ...
Mar 16, 2024
0
56
For the 2021 to 2022 influenza season, influenza vaccines were 36 percent effective against influenza A(H3N2)-related illnesses, according to a study published online Dec. 12 in Clinical Infectious Diseases.
Jan 4, 2023
0
22
As COVID-related hospitalizations once again increase across the U.S., experts are researching the newly identified variants, their transmissibility and possible mutations. How concerned should the public be about these new ...
Aug 30, 2023
0
14
Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses, new research suggests.
Dec 1, 2022
0
50
You've seen the commercial. The one that ominously tells you if you had chickenpox as a child, the virus that causes shingles is already inside you.
Aug 8, 2023
0
65
The head of the World Health Organization told the Financial Times he was ready to send a new mission of experts to China to investigate the origins of COVID-19.
Sep 17, 2023
0
2
A new study from the Texas A&M University School of Public Health found that only 9 percent of older Americans had been vaccinated against respiratory syncytial virus (RSV) prior to this fall and winter, despite the threat ...
Mar 2, 2024
1
59
A few years ago, a patient was cured of multiple myeloma after being treated for hepatitis C, astounding researchers from the group led by Joaquín Martínez, from the H12O-CNIO Hematological Tumours Clinical Research Unit, ...
Jan 19, 2024
0
98
